Large populations are susceptible to respiratory diseases because of COVID-19 intervention policies but reinstating nonpharmaceutical interventions at the correct time can help slow the spread Governments around the...
Researchers at Georgia State University say their findings, published July 14 in the International Journal of Nanomedicine, suggest their nano-engineered vaccine induces long-term protection against respiratory...
Computational biologist Jue Wang was already striving to develop an artificial intelligence (AI) to churn out candidate medicines when he had to rush his 2-year-old son to the hospital with a potentially lethal...
Respiratory syncytial virus (RSV) is common cause of infections such as pneumonia. Most cases and deaths in young children occur in lower-income countries. Passive immunisation campaign urged for babies under six months...
The pandemic is changing the genetic landscape of virus strains A University of Sydney- led study reveals how the pandemic has changed the normal patterns of winter viruses in Australia, with new strains emerging and...
Close interactions with infectious disease set both UC Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying respiratory syncytial...
Background Understanding the transmission and dispersal of iinfluenza and respiratory syncytial virus (RSV) via aerosolsvia aerosols is essential for the development of preventative measures in hospital environments and...
A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success. A new study from The Ohio State University provides...
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers...
Researchers at Georgia State University say a vaccine containing virus-like microscopic, genetically engineered particles — i.e.: nanoparticles, has been shown to be an effective treatment for respiratory syncytial...